CSPC Pharmaceutical Group Ltd. (CSPCY)
4.67
-0.04
(-0.85%)
USD |
OTCM |
Jan 09, 16:00
CSPC Pharmaceutical Group Enterprise Value: 13.07B for Jan. 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Innovent Biologics, Inc. | -- |
| Sinovac Biotech Ltd. | -- |
| China Pharma Holdings, Inc. | 7.547M |
| CASI Pharmaceuticals, Inc. | 36.77M |
| Zai Lab Ltd. | 1.457B |
Enterprise Value Related Metrics
| Earnings Yield | 3.97% |
| Operating Earnings Yield | 4.35% |
| Normalized Earnings Yield | 3.872 |